Lifeward’s ReWalk™ Personal Exoskeleton Now Covered by Aetna, Coverage Expands to Include Three of the Largest Medicare Advantage Insurers
View original at finance.yahoo.comLifeward’s ReWalk™ Personal Exoskeleton Now Covered by Aetna, Coverage Expands to Include Three of the Largest Medicare Advantage Insurers Lifeward Ltd…
What we drew from this source
The claims Via News extracted from this document. We point to the source; we don't replace it.
Aetna's decision represents meaningful progress in expanding access to evidence-based advanced rehabilitation technology
80% confidenceMultiple peer-reviewed studies have demonstrated the ReWalk Personal Exoskeleton System's benefits related to ambulation, musculoskeletal health, and cardiopulmonary function
80% confidenceThree of the largest Medicare Advantage insurers represent approximately 16 million beneficiaries across the United States
80% confidenceAs leading Medicare Advantage insurers independently review the clinical evidence and reach consistent medical necessity determinations, it reinforces that exoskeleton-assisted walking serves as an appropriate therapeutic intervention for qualified individuals living with spinal cord injury
80% confidence
Cited in these Via News reports
- AI Warehouse Robots Hit 98% Accuracy as Global Autonomous Vehicle Rollout Targets 2026 →
- Autonomous Robots Enter Consumer Markets Globally as LiDAR and AI Navigation Mature in 2026 →
- Boston Dynamics Atlas Research Platform Completes Final Tests as Commercial Humanoid Deploys Globally →
- Global Robotics Deployments Hit 40+ Units in Q1 as US Defense Opens Procurement to AI Startups →
- Robotaxis Enter Commercial Service in 2026 as Global Robotics Industry Scales from Research to Production →
- Robotics Firms Set 2026-2028 Timeline for Commercial Launch Across Three Continents →
- Warehouse Bot Hits 98% Accuracy as Robotaxi Production Targets Late 2026 →
